Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

ULTRAVIST (PHARMACY BULK)

IOPROMIDE

Standard Dose
49.9%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ULTRAVIST (PHARMACY BULK) is listed in Drugs@FDA under application 021425 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient IOPROMIDE Form and strength INJECTABLE;INJECTION - 49.9% Sponsor BAYER HLTHCARE Submission history Latest submission status date: 2023-06-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview ULTRAVIST (PHARMACY BULK) is listed in Drugs@FDA under application 021425 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient IOPROMIDE Form and strength INJECTABLE;INJECTION - 49.9% Sponsor BAYER HLTHCARE Submission history Latest submission status date: 2023-06-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.